Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review (Q34871254)

5 August 2017

Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review (English)

1 reference

5 August 2017

1 reference

Bhavarth S Shukla

1

1 reference

5 August 2017

Timothy P Gauthier

2

1 reference

5 August 2017

Ricardo Correa

3

1 reference

5 August 2017

Laura Smith

4

1 reference

5 August 2017

Lilian Abbo

5

1 reference

5 August 2017

27 July 2013

1 reference

International Journal of Clinical Pharmacy

5 August 2017

1 reference

5 August 2017

35

1 reference

5 August 2017

5

1 reference

5 August 2017

697-703

1 reference

https://scigraph.springernature.com/pub.10.1007/s11096-013-9825-5

5 August 2017

0 references

cites work

Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

The rise of the Enterococcus: beyond vancomycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Vancomycin-resistant enterococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Vancomycin resistance in gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

A potential role for daptomycin in enterococcal infections: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

21 January 2018

Oxazolidinones: a review

1 reference

https://api.crossref.org/works/10.1007%2FS11096-013-9825-5

Vancomycin-resistant enterococci

21 January 2018

1 reference

12 December 2020

Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

1 reference

12 December 2020

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program

1 reference

12 December 2020

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)

1 reference

12 December 2020

Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan

1 reference

12 December 2020

Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).

1 reference

12 December 2020

10.1007/S11096-013-9825-5

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference